Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China

  • Wei Yan ,

    Contributed equally to this work with: Wei Yan, Wei Zhang, Gan You

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Wei Zhang ,

    Contributed equally to this work with: Wei Yan, Wei Zhang, Gan You

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Gan You ,

    Contributed equally to this work with: Wei Yan, Wei Zhang, Gan You

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Zhaoshi Bao,

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Yongzhi Wang,

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Yanwei Liu,

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Chunsheng Kang,

    Affiliation Laboratory of Neuro-oncology, Tianjin Neurological Institute, Tianjin, China

  • Yongping You,

    Affiliation Department of Neurosurgery, Nanjing Medical University, The First Affiliated Hospital, Nanjing, China

  • Lei Wang ,

    wangleitiantan@126.com (LW); taojiang1964@yahoo.com.cn (TJ)

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

  • Tao Jiang

    wangleitiantan@126.com (LW); taojiang1964@yahoo.com.cn (TJ)

    Affiliation Department of Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.